Brown Advisory’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,234
| Closed | -$229K | – | 1268 |
|
|
2024
Q2 | $229K | Buy |
4,234
+500
| +13% | +$27K | ﹤0.01% | 1143 |
|
|
2024
Q1 | $255K | Sell |
3,734
-21
| -0.6% | -$1.43K | ﹤0.01% | 1113 |
|
|
2023
Q4 | $235K | Buy |
+3,755
| New | +$235K | ﹤0.01% | 1123 |
|
|
2022
Q4 | – | Sell |
-5,057
| Closed | -$331K | – | 1213 |
|
|
2022
Q3 | $331K | Buy |
5,057
+948
| +23% | +$62.1K | ﹤0.01% | 944 |
|
|
2022
Q2 | $249K | Sell |
4,109
-220
| -5% | -$13.3K | ﹤0.01% | 990 |
|
|
2022
Q1 | $272K | Buy |
4,329
+1,282
| +42% | +$80.6K | ﹤0.01% | 990 |
|
|
2021
Q4 | $231K | Sell |
3,047
-30
| -1% | -$2.27K | ﹤0.01% | 1132 |
|
|
2021
Q3 | $344K | Sell |
3,077
-1,042
| -25% | -$116K | ﹤0.01% | 909 |
|
|
2021
Q2 | $667K | Buy |
4,119
+40
| +1% | +$6.48K | ﹤0.01% | 793 |
|
|
2021
Q1 | $497K | Buy |
4,079
+1,057
| +35% | +$129K | ﹤0.01% | 848 |
|
|
2020
Q4 | $462K | Buy |
+3,022
| New | +$462K | ﹤0.01% | 797 |
|